Target intelligence / Profile preview

Quorum sensing pathways in Pseudomonas aeruginosa and Staphylococcus aureus (QS pathways (P. aeruginosa/S. aureus))

Target
QS pathways (P. aeruginosa/S. aureus)
Molecular classification
Transcription factor, Enzyme, Receptor protein-tyrosine kinase, Histidine kinase, Acyl-homoserine-lactone synthase
01

Overview

Quorum sensing (QS) pathways are sophisticated chemical communication systems used by bacteria to coordinate collective behaviors based on population density. In Pseudomonas aeruginosa, a Gram-negative pathogen, the system primarily relies on acyl-homoserine lactones (AHLs) and quinolone signals (PQS) acting through LuxR-type transcription factors like LasR and RhlR to regulate virulence factors and biofilm architecture. In Staphylococcus aureus, a Gram-positive pathogen, the Accessory Gene Regulator (Agr) system utilizes autoinducing peptides (AIPs) and a two-component signaling system (AgrC/AgrA) to switch between colonizing and invasive phenotypes. These pathways are critical therapeutic targets because their inhibition, known as quorum quenching, can attenuate bacterial pathogenicity and increase susceptibility to antibiotics without directly killing the bacteria, potentially reducing the selective pressure for resistance. Targeting these systems is particularly relevant for treating chronic infections such as those found in cystic fibrosis lungs or non-healing wounds where biofilms are prevalent.

Other names
Bacterial cell-to-cell communicationLasI/LasR systemRhlI/RhlR systemPQS systemAgr systemAccessory gene regulator systemQuorum quenching targets
02

Mechanism of action

Inhibition of autoinducer synthesis, competitive antagonism of quorum sensing receptors, enzymatic degradation of signaling molecules (quorum quenching), and inhibition of downstream response regulators.

03

Biological functions

Signal transductionVirulence factor regulationBiofilm formationBacterial population density sensingInterspecies communication
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsisSkin and soft tissue infection (SSTI)Chronic wound infection
05

Safety considerations

Disruption of commensal microbiomePotential for compensatory mutationsLimited efficacy as monotherapyHost toxicity of certain synthetic inhibitors
06

Interacting drugs

Azithromycin

6 more in the full profile.

07

Biomarkers

3-oxo-C12-HSL levelsC4-HSL levelsAutoinducing peptide (AIP) levelsRNAIII expressionPyocyanin productionElastase activity

Beyond the preview

Go deeper on Quorum sensing pathways in Pseudomonas aeruginosa and Staphylococcus aureus (QS pathways (P. aeruginosa/S. aureus)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quorum sensing pathways in Pseudomonas aeruginosa and Staphylococcus aureus (QS pathways (P. aeruginosa/S. aureus)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call